Literature DB >> 24118596

Acquired factor V deficiency in a patient without evidence of a classical inhibitor.

I R Sosa1, P Ellery, A Mast, A T Neff, D Gailani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24118596      PMCID： PMC3870044          DOI： 10.1111/hae.12280

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  9 in total

Review 1.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

Review 2.  Inherited and acquired factor V deficiency.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Martina Montagnana; Franco Manzato; Gian C Guidi; Massimo Franchini
Journal:  Blood Coagul Fibrinolysis       Date:  2011-04       Impact factor: 1.276

3.  Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.

Authors:  M Christella L G D Thomassen; Elisabetta Castoldi; Guido Tans; Elke J P Magdeleyns; Christian Delaunoit; Louisette Debusscher; Kris J A J Van Assche; Jan Rosing
Journal:  Haematologica       Date:  2003-10       Impact factor: 9.941

4.  Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.

Authors:  Connie Duckers; Paolo Simioni; Luca Spiezia; Claudia Radu; Sabrina Gavasso; Jan Rosing; Elisabetta Castoldi
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

5.  Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.

Authors:  Connie Duckers; Paolo Simioni; Luca Spiezia; Claudia Radu; Paolo Dabrilli; Sabrina Gavasso; Jan Rosing; Elisabetta Castoldi
Journal:  Blood       Date:  2009-10-27       Impact factor: 22.113

Review 6.  Advances in understanding the bleeding diathesis in factor V deficiency.

Authors:  Connie Duckers; Paolo Simioni; Jan Rosing; Elisabetta Castoldi
Journal:  Br J Haematol       Date:  2009-04-27       Impact factor: 6.998

Review 7.  Factor-X deficiency in amyloidosis: a critical review.

Authors:  P R Greipp; R A Kyle; E J Bowie
Journal:  Am J Hematol       Date:  1981-12       Impact factor: 10.047

8.  Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.

Authors:  Y Emori; M Sakugawa; K Niiya; T Kiguchi; K Kojima; K Takenaka; K Shinagawa; F Ishimaru; K Ikeda; M Tanimoto; R Yamasaki; N Ohara; M Harada
Journal:  Blood Coagul Fibrinolysis       Date:  2002-09       Impact factor: 1.276

Review 9.  Tissue factor pathway inhibitor: structure-function.

Authors:  George J Broze; Thomas J Girard
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01
  9 in total
  3 in total

1.  Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency.

Authors:  Michelle M Castillo; Qiuhui Yang; Min Zhan; Amy Y Pan; Michael W Lawlor; Alan E Mast; Rashmi Sood
Journal:  Blood Adv       Date:  2019-02-12

2.  A Case of Acquired Factor V Deficiency in Patient with Bleeding.

Authors:  Davide Vetri; Giovanni Lumera; Salvatore Tarascio; Salvatore Scuto; Elisa Marino; Giuliana Barcellona; Salvatore Santo Signorelli
Journal:  TH Open       Date:  2020-04-20

3.  Challenges in management of unusual acquired factor V deficiency: A case report.

Authors:  Kiyoshi Takemoto; Osamu Hamada; Koichi Kitamura; Naoki Fujiwara; Yoshitaka Miyakawa
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.